Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Gaush Meditech Ltd. ( (HK:2407) ) has provided an announcement.
Gaush Meditech Ltd announced that its subsidiary, Gaush Neotech, has obtained a national medical device registration certificate for its corneal confocal microscopes T3–600 and T3–400. These devices, featuring a wide field of view and high resolution, represent a technological breakthrough in China, improving the diagnosis of various corneal and conjunctival diseases. The company plans to enhance these products with AI technology for automatic image analysis, aiming to improve diagnostic efficiency and accuracy. Additionally, the CE registration process for these products has commenced.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd is a company incorporated in the Cayman Islands, operating in the medical technology industry. It focuses on developing innovative medical devices, with a market focus on enhancing diagnostic tools and technologies.
YTD Price Performance: -46.80%
Average Trading Volume: 454,600
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$738M
For a thorough assessment of 2407 stock, go to TipRanks’ Stock Analysis page.